296 related articles for article (PubMed ID: 28176204)
1. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives.
Hunter JE; Arnold KA; Cook JE; Zepp J; Gilmore MJ; Rope AF; Davis JV; Bergen KM; Esterberg E; Muessig KR; Peterson SK; Syngal S; Acheson L; Wiesner G; Reiss J; Goddard KAB
Fam Cancer; 2017 Jul; 16(3):377-387. PubMed ID: 28176204
[TBL] [Abstract][Full Text] [Related]
2. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
3. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
5. Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities.
Vindigni SM; Kaz AM
Dig Dis Sci; 2016 Apr; 61(4):969-76. PubMed ID: 26602911
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry: A Cohort Study.
Li D; Hoodfar E; Jiang SF; Udaltsova N; Pham NP; Jodesty Y; Armstrong MA; Hung YY; Baker RJ; Postlethwaite D; Ladabaum U; Levin TR; Corley DA; Bergoffen J
Ann Intern Med; 2019 Jul; 171(1):19-26. PubMed ID: 31181578
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A
J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606
[TBL] [Abstract][Full Text] [Related]
8. Universal Screening for Lynch Syndrome Compared with Pedigree-Based Screening: 10-Year Experience in a Tertiary Hospital.
Kim MH; Kim DW; Lee HS; Bang SK; Seo SH; Park KU; Oh HK; Kang SB
Cancer Res Treat; 2023 Jan; 55(1):179-188. PubMed ID: 35313100
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer.
Siraj AK; Prabhakaran S; Bavi P; Bu R; Beg S; Hazmi MA; Al-Rasheed M; Al-Assiri M; Sairafi R; Al-Dayel F; Al-Sanea N; Uddin S; Al-Kuraya KS
Cancer; 2015 Jun; 121(11):1762-71. PubMed ID: 25712738
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
[TBL] [Abstract][Full Text] [Related]
11. Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.
Katz LH; Burton-Chase AM; Advani S; Fellman B; Polivka KM; Yuan Y; Lynch PM; Peterson SK
Clin Genet; 2016 Mar; 89(3):392-8. PubMed ID: 26272410
[TBL] [Abstract][Full Text] [Related]
12. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.
Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG
Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327
[TBL] [Abstract][Full Text] [Related]
13. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello F
Fam Cancer; 2021 Apr; 20(2):145-156. PubMed ID: 32914371
[TBL] [Abstract][Full Text] [Related]
14. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
15. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
16. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers.
Mittal C; Dang D; Stoffel E; Menees S; Scott FI; Ahnen D; Patel SG
Dig Dis Sci; 2020 Nov; 65(11):3305-3315. PubMed ID: 32500284
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening.
Cragun D; Malo TL; Pal T; Shibata D; Vadaparampil ST
Genet Test Mol Biomarkers; 2012 Jun; 16(6):493-9. PubMed ID: 22224634
[TBL] [Abstract][Full Text] [Related]
19. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
20. What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients.
Tiernan G; Freeman V; Morrow A; Hogden E; Canfell K; Kang YJ; Taylor N
Psychooncology; 2022 Apr; 31(4):587-596. PubMed ID: 34698409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
